Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4
Authors:
- 10 February 2022
- journal article
- research article
- Published by Elsevier in Cell Chemical Biology
- Vol. 29 (6) , 970-984.e6
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (AG062617)
- National Institutes of Health (GM054403)
- National Institutes of Health (AI125362)
- National Institutes of Health (CA264984)
- Comprehensive Cancer Center at Wake Forest Baptist Medical Center (P30CA012197)
- Roswell Park Alliance Foundation
- Roswell Park Comprehensive Cancer Center
- National Cancer Institute (P30CA012197)
- National Cancer Institute (P30CA16056)
- National Cancer Institute (CA247819)
- National Cancer Institute (CA224434)
- National Cancer Institute (CA248018)
This publication has 108 references indexed in Scilit:
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanomaNature Genetics, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Eph and ephrin signaling in the formation of topographic mapsSeminars in Cell & Developmental Biology, 2012
- Epha2 is a critical oncogene in melanomaOncogene, 2011
- Eph receptors and ephrins in cancer: bidirectional signalling and beyondNature Reviews Cancer, 2010
- Coordination of Rho GTPase activities during cell protrusionNature, 2009
- Eph-Ephrin Bidirectional Signaling in Physiology and DiseaseCell, 2008
- Profiling signaling polarity in chemotactic cellsProceedings of the National Academy of Sciences, 2007
- GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factorsNature Reviews Molecular Cell Biology, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004